[A case report-highly advanced gastric cancer leading to perforation during neoadjuvant chemotherapy with docetaxel, cisplatin and S-1].

Koki Mihara, Tomohisa Egawa, Takeshi Kemmochi, Tomoyuki Irino, Akihiko Okamura, Yusaku Inaba, Eiichi Eto, Kenki Segami, Yasuhiro Ito, Shinobu Hayashi, Atsushi Nagashima

Research output: Contribution to journalArticle

Abstract

A 70-year-old man was found to have advanced gastric cancer with a deep ulcer and multiple lymph-node metastases. Although the tumor was resectable, we predicted that the patient would have a poor outcome. We therefore administered neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 to improve the prognosis before curative resection. On day 15 of chemotherapy, sudden abdominal pain occurred, and we performed an emergency surgery for a diagnosis of panperitonitis due to gastric cancer perforation. The defect in the gastric wall was about 2 cm in diameter and was located in the anterior wall of the antrum, consistent with the center of the tumor. The operative findings suggested that the perforation was caused by chemotherapy-induced necrosis of gastric cancer cells. We saved the patient's life, but intensive care with high-dose catecholamine therapy was needed for several days after the surgery. Gastric cancer perforation induced by neoadjuvant chemotherapy appeared to be more severe than perforation caused by other factors. The adverse effects of chemotherapy apparently increased the severity. Our findings suggest that the risk of gastric cancer perforation should be borne in mind when we administer neoadjuvant chemotherapy to patients who have advanced gastric cancer with a deep ulcer.

Original languageEnglish
Pages (from-to)2357-2359
Number of pages3
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume38
Issue number12
Publication statusPublished - 2011 Jan 1
Externally publishedYes

Fingerprint

docetaxel
Cisplatin
Stomach Neoplasms
Drug Therapy
Ulcer
Critical Care
Ambulatory Surgical Procedures
Abdominal Pain
Catecholamines
Neoplasms
Stomach
Emergencies
Necrosis
Lymph Nodes
Neoplasm Metastasis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

[A case report-highly advanced gastric cancer leading to perforation during neoadjuvant chemotherapy with docetaxel, cisplatin and S-1]. / Mihara, Koki; Egawa, Tomohisa; Kemmochi, Takeshi; Irino, Tomoyuki; Okamura, Akihiko; Inaba, Yusaku; Eto, Eiichi; Segami, Kenki; Ito, Yasuhiro; Hayashi, Shinobu; Nagashima, Atsushi.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 38, No. 12, 01.01.2011, p. 2357-2359.

Research output: Contribution to journalArticle

Mihara, K, Egawa, T, Kemmochi, T, Irino, T, Okamura, A, Inaba, Y, Eto, E, Segami, K, Ito, Y, Hayashi, S & Nagashima, A 2011, '[A case report-highly advanced gastric cancer leading to perforation during neoadjuvant chemotherapy with docetaxel, cisplatin and S-1].', Gan to kagaku ryoho. Cancer & chemotherapy, vol. 38, no. 12, pp. 2357-2359.
Mihara, Koki ; Egawa, Tomohisa ; Kemmochi, Takeshi ; Irino, Tomoyuki ; Okamura, Akihiko ; Inaba, Yusaku ; Eto, Eiichi ; Segami, Kenki ; Ito, Yasuhiro ; Hayashi, Shinobu ; Nagashima, Atsushi. / [A case report-highly advanced gastric cancer leading to perforation during neoadjuvant chemotherapy with docetaxel, cisplatin and S-1]. In: Gan to kagaku ryoho. Cancer & chemotherapy. 2011 ; Vol. 38, No. 12. pp. 2357-2359.
@article{8899070ddeec49eb8d98752f0c9fdd8c,
title = "[A case report-highly advanced gastric cancer leading to perforation during neoadjuvant chemotherapy with docetaxel, cisplatin and S-1].",
abstract = "A 70-year-old man was found to have advanced gastric cancer with a deep ulcer and multiple lymph-node metastases. Although the tumor was resectable, we predicted that the patient would have a poor outcome. We therefore administered neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 to improve the prognosis before curative resection. On day 15 of chemotherapy, sudden abdominal pain occurred, and we performed an emergency surgery for a diagnosis of panperitonitis due to gastric cancer perforation. The defect in the gastric wall was about 2 cm in diameter and was located in the anterior wall of the antrum, consistent with the center of the tumor. The operative findings suggested that the perforation was caused by chemotherapy-induced necrosis of gastric cancer cells. We saved the patient's life, but intensive care with high-dose catecholamine therapy was needed for several days after the surgery. Gastric cancer perforation induced by neoadjuvant chemotherapy appeared to be more severe than perforation caused by other factors. The adverse effects of chemotherapy apparently increased the severity. Our findings suggest that the risk of gastric cancer perforation should be borne in mind when we administer neoadjuvant chemotherapy to patients who have advanced gastric cancer with a deep ulcer.",
author = "Koki Mihara and Tomohisa Egawa and Takeshi Kemmochi and Tomoyuki Irino and Akihiko Okamura and Yusaku Inaba and Eiichi Eto and Kenki Segami and Yasuhiro Ito and Shinobu Hayashi and Atsushi Nagashima",
year = "2011",
month = "1",
day = "1",
language = "English",
volume = "38",
pages = "2357--2359",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "12",

}

TY - JOUR

T1 - [A case report-highly advanced gastric cancer leading to perforation during neoadjuvant chemotherapy with docetaxel, cisplatin and S-1].

AU - Mihara, Koki

AU - Egawa, Tomohisa

AU - Kemmochi, Takeshi

AU - Irino, Tomoyuki

AU - Okamura, Akihiko

AU - Inaba, Yusaku

AU - Eto, Eiichi

AU - Segami, Kenki

AU - Ito, Yasuhiro

AU - Hayashi, Shinobu

AU - Nagashima, Atsushi

PY - 2011/1/1

Y1 - 2011/1/1

N2 - A 70-year-old man was found to have advanced gastric cancer with a deep ulcer and multiple lymph-node metastases. Although the tumor was resectable, we predicted that the patient would have a poor outcome. We therefore administered neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 to improve the prognosis before curative resection. On day 15 of chemotherapy, sudden abdominal pain occurred, and we performed an emergency surgery for a diagnosis of panperitonitis due to gastric cancer perforation. The defect in the gastric wall was about 2 cm in diameter and was located in the anterior wall of the antrum, consistent with the center of the tumor. The operative findings suggested that the perforation was caused by chemotherapy-induced necrosis of gastric cancer cells. We saved the patient's life, but intensive care with high-dose catecholamine therapy was needed for several days after the surgery. Gastric cancer perforation induced by neoadjuvant chemotherapy appeared to be more severe than perforation caused by other factors. The adverse effects of chemotherapy apparently increased the severity. Our findings suggest that the risk of gastric cancer perforation should be borne in mind when we administer neoadjuvant chemotherapy to patients who have advanced gastric cancer with a deep ulcer.

AB - A 70-year-old man was found to have advanced gastric cancer with a deep ulcer and multiple lymph-node metastases. Although the tumor was resectable, we predicted that the patient would have a poor outcome. We therefore administered neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 to improve the prognosis before curative resection. On day 15 of chemotherapy, sudden abdominal pain occurred, and we performed an emergency surgery for a diagnosis of panperitonitis due to gastric cancer perforation. The defect in the gastric wall was about 2 cm in diameter and was located in the anterior wall of the antrum, consistent with the center of the tumor. The operative findings suggested that the perforation was caused by chemotherapy-induced necrosis of gastric cancer cells. We saved the patient's life, but intensive care with high-dose catecholamine therapy was needed for several days after the surgery. Gastric cancer perforation induced by neoadjuvant chemotherapy appeared to be more severe than perforation caused by other factors. The adverse effects of chemotherapy apparently increased the severity. Our findings suggest that the risk of gastric cancer perforation should be borne in mind when we administer neoadjuvant chemotherapy to patients who have advanced gastric cancer with a deep ulcer.

UR - http://www.scopus.com/inward/record.url?scp=84858811559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858811559&partnerID=8YFLogxK

M3 - Article

C2 - 22202381

AN - SCOPUS:84858811559

VL - 38

SP - 2357

EP - 2359

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 12

ER -